Cercar
07/08/2024
Consensus statement addressing controversies and guidelines on pediatric urolithiasis
Güven, S, Tokas, T, Tozsin, A, Haid, B, Lendvay, TS, Silay, S, Mohan, VC, Cansino, JR, Saulat, S, Straub, M, Tur, AB, Akgül, B, Samotyjek, J, Lusuardi, L, Ferretti, S, Cavdar, OF, Ortner, G, Sultan, S, Choong, S, Micali, S, Saltirov, I, Sezer, A, Netsch, C, de Lorenzis, E, Cakir, OO, Zeng, G, Gozen, AS, Bianchi, G, Jurkiewicz, B, Knoll, T, Rassweiler, J, Ahmed, K, Sarica, K. Consensus statement addressing controversies and guidelines on pediatric urolithiasis. WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05161-4. PMID:39110242. IF:2.900(Q2/3D).
01/03/2026
Real-world data support restaging at reTURB for prognostic re-stratification of EAU 2021 risk groups in high-grade T1 non-muscle-invasive bladder cancer: A data-driven, risk-adapted guide to timely radical cystectomy decisions
Diaz, AFM, Henriquez, JDS, Ojeda, CM, Medina, AA, Duran, PD, Serrano, GM, Dos Santos, VG, Krajewski, W, Pichler, R, Scilipoti, P, Longoni, M, De Angelis, M, Moschini, M, Velasco, JC, Aumatell, J, Contieri, R, Gallioli, A, Slusarczyk, A, Grobet-Jeandin, E, Del Giudice, F, Soria, F, Mertens, L, Pradere, B, Revilla, FJB. Real-world data support restaging at reTURB for prognostic re-stratification of EAU 2021 risk groups in high-grade T1 non-muscle-invasive bladder cancer: A data-driven, risk-adapted guide to timely radical cystectomy decisions. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2026
Sasanlimab plus bacillus Calmette-Guérin in BCG-naive, high-risk non-muscle-invasive bladder cancer (NMIBC): Exploratory biomarker analysis of the phase 3 CREST trial.
Galsky, MD, Lin, GHY, Shore, ND, Steinberg, GD, Bedke, J, Palou, J, Brinkmann, J, Calella, AM, Cesari, R, Davis, C, Rosenthal, S, Yang, WJ, Ching, KA, Saul, M, Vasaikar, SV, Powles, T. Sasanlimab plus bacillus Calmette-Guérin in BCG-naive, high-risk non-muscle-invasive bladder cancer (NMIBC): Exploratory biomarker analysis of the phase 3 CREST trial.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(7_SUPPL)DOI:10.1200/JCO.2026.44.7_suppl.806. PMID:. IF:41.900(Q1/1D).
01/03/2026
Risk of recurrence and progression after endoscopic kidney-sparing surgery for upper tract urothelial carcinoma: An EAU-YAU urothelial proposal
Gallioli, A, Di Bello, F, D'Andrea, D, Zattoni, F, Soria, F, Krajewski, W, Laukhtina, E, Marcq, G, Moschini, M, Izquierdo, P, Afferi, L, Mari, A, Del Giudice, F, Dieguez, L, Donnini, I, Avesani, G, Subiela, G, Basile, G, De Lorenzis, E, Chung, B, Territo, A, Palou, J, Pradere, B, Breda, A. Risk of recurrence and progression after endoscopic kidney-sparing surgery for upper tract urothelial carcinoma: An EAU-YAU urothelial proposal. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2026
Utility and challenges of Flexible and Navigable Suction Ureteral Access Sheath (FANS) vs. suction mini-PCNL in children: A comparative analysis
Lim, EJ, Yuen, SKK, Herrmann, TRW, Sarica, K, Tur, AB, Teng, R, Quiroz, YM, Kalathia, J, Tak, GR, Chong, T, Fong, KY, Tursunkulov, AN, Tanidir, Y, Joshi, R, Mohan, VC, Traxer, O, Castellani, D, Gauhar, V. Utility and challenges of Flexible and Navigable Suction Ureteral Access Sheath (FANS) vs. suction mini-PCNL in children: A comparative analysis. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2026
Trifecta in Robot-Assisted Kidney Transplantation (RAKT) from living donors: Insights from 8-years ERUS-RAKT experience
Territo, A, Avesani, G, Di Bello, F, Belarmino, A, Gallioli, A, Campi, R, Afferi, L, Gaya, JM, Pecoraro, A, Decaestecker, K, Musquera, M, Etcheverry, B, Vangeneugden, J, Rodriguez, BLD, Mercier, J, Ortved, M, Zeuschner, P, Volpe, A, Idu, M, Kocak, B, Vigues, F, Alcaraz, A, Serni, S, Breda, A. Trifecta in Robot-Assisted Kidney Transplantation (RAKT) from living donors: Insights from 8-years ERUS-RAKT experience. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).